Dynamic laboratory control of iron deficiency correction in neurosurgical patients

Introduction. The concept of blood management in relation to the surgical treatment diseases recommends correction iron defi ciency anemia (IDA) at prehospital stage. However, surgery is often performed for emergency indications, making it necessary carry out as soon possible. Aim – evaluate possibilities using delta hemoglobin (Delta-He) monitor effectiveness IDA therapy neurosurgical patients stage reduce time required prepare hospitalization. Materials and methods. A total 42 were treated with high-dose preparations (iron [III] carboxymaltosate hydroxide oligoisomaltosate). During treatment, dynamics number reticulocytes values evaluated. Data are presented median (IQR). Results. Treatment led an increase Delta-He starting from days 1–2. Significant changes recorded by 3–4 start therapy: 2.2 (0.3–4.9) pg 15.5 (13.8–10) on day 7. These 2–3 ahead corresponding samples: significantly increased 5–6 treatment. Conclusion. use oligoisomaltosate form infusion made possible hospitalization within a week. None transfusion erythrocyte-containing components donated any ability focus instead during shorten waiting period effect drug exposure days.